InsiderTrades

Form 4 for QXL QUANTUM X LABS INC.

Accepted 2025-03-21 00:00:00 ET · period of report 2024-06-18 · accession 0001493152-25-011076 · SEC index · Original document

Summary rows

Aggregated the way they appear in lists: one row per insider, transaction code and security table.

X Filed Traded Ticker Insider Title Type Price Qty Owned ΔOwn Value
D 2025-03-21 2024-06-18 QXL Marom Shahar CFO P - Purchase $1.00 +1,259 5,018 +33% +$1,259
D 2025-03-21 2024-06-18 QXL Marom Shahar CFO P - Purchase $1.00 +1,259 5,018 +33% +$1,259

Purchase Sale Sale after option exercise All abbreviations

Every reported transaction

#TableSecurityDateCodeA/DSharesPriceOwned afterOwnExercise / expiryUnderlyingFootnotes
1 Common Common Stock, par value $0.0001 per share 2024-06-18 P A 1,259 $1.00 5,018 D — — (F1) The shares of common stock were issued by the Company to the reporting person upon the conversion of outstanding interest, at a conversion rate of $1.00, due under a loan provided by the reporting person pursuant to the facility agreement between the Company, the reporting person and the other lenders listed therein (the "Facility Agreement"). (F3) Includes a warrant to purchase 2,500 shares of common stock, par value $0.0001 per share, that was previously issued by the Company to the reporting person, which is currently exercisable or exercisable within 60 days of March 21, 2025.
2 Derivative Warrant to purchase common stock 2024-06-18 P A 1,259 $1.00 5,018 D $1.00 · 2024-06-18 to 2027-06-18 1,259 Common Stock (F2) The warrants to purchase common stock, par value $0.0001 per share was issued by the Company to the reporting person, upon the conversion of outstanding interest, at a conversion rate of $1.00 due under a loan provided by the reporting person pursuant to the Facility Agreement. (F3) Includes a warrant to purchase 2,500 shares of common stock, par value $0.0001 per share, that was previously issued by the Company to the reporting person, which is currently exercisable or exercisable within 60 days of March 21, 2025.